Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities, and Psychiatric Symptoms on Patients With Bipolar Disorder (BPD).

Předmět:	PEOPLE with mental illness KETOGENIC diet COMPULSIVE eating BIPOLAR disorder BORDERLINE personality disorder ACETONEMIA METABOLIC disorders OBESITY CARDIOVASCULAR diseases
Zdroj:	Clinical Trials Week; 2/13/2023, p777-777, 1p
Abstrakt:	Keywords: Clinical Trial Identifier NCT05705063; Lipid Research; Lipids; Lipoproteins; Peptide Hormones; Peptide Proteins; Proinsulin; Psychiatric; Psychiatry; Risk and Prevention; Therapy EN Clinical Trial Identifier NCT05705063 Lipid Research Lipids Lipoproteins Peptide Hormones Peptide Proteins Proinsulin Psychiatric Psychiatry Risk and Prevention Therapy 2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Staff editors report on the newly launched clinical trial, NCT05705063, which has the following summary description: "To initiate a low-carbohydrate, high-fat (LCHF) or ketogenic dietary (KD) intervention among a cohort of outpatients with bipolar illness who also have metabolic abnormalities, overweight/obesity, and/or are currently taking psychotropic medications experiencing metabolic side effects." ECollection 2022.
	https://www.ncbi.nlm.nih.gov/pubmed?term=36483840 - Sethi S, Ford JM. 2022 Nov 29;14(23):5074. doi: 10.3390/nu14235074.
	https://www.ncbi.nlm.nih.gov/pubmed?term=32773576 - Sethi S, Sinha A, Gearhardt AN. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu